These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2172869)

  • 21. [Approaches to pathogenetic immunotherapy of HIV-infections].
    Nikol'skiĭ IS; Iurchenko VD
    Lik Sprava; 2002; (7):7-14. PubMed ID: 12587295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of catecholamine degradation ameliorates while chemical sympathectomy aggravates the severity of acute Friend retrovirus infection in mice.
    Bloemker D; Mollerus S; Gibbert K; Dittmer U; Del Rey A; Schedlowski M; Engler H
    Brain Behav Immun; 2016 May; 54():252-259. PubMed ID: 26880342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Search for retrovirus expression in men--failure to demonstrate retrovirus-specific antigens in normal and malignant tissue.
    Micheel B; Wunderlich V; Hertling I
    Arch Geschwulstforsch; 1982 May; 52(3):169-173. PubMed ID: 6289769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tsl and LP-BM5: a comparison of two murine retrovirus models for HIV.
    Clark S; Duggan J; Chakraborty J
    Viral Immunol; 2001; 14(2):95-109. PubMed ID: 11398815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Future considerations for dendritic cell immunotherapy against chronic viral infections.
    Atanley E; van Drunen Littel-van den Hurk S
    Expert Rev Clin Immunol; 2014 Jun; 10(6):801-13. PubMed ID: 24734867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active immune therapy for the treatment of HIV infections.
    Letvin NL; Chen ZW; Yamamoto H; Watanabe M
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1499. PubMed ID: 1466989
    [No Abstract]   [Full Text] [Related]  

  • 27. Immune-based therapy for HIV.
    Engle J
    Nurs Clin North Am; 1996 Mar; 31(1):15-23. PubMed ID: 8604377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Retrovirus: diagnostic tests and their interpretation (I). Generalities and infection by HIV-1].
    Soriano V; Gutiérrez M; González-Lahoz J
    Med Clin (Barc); 1993 Jul; 101(6):219-26. PubMed ID: 8392655
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunological effects of antiretroviral and immune therapies for HIV.
    Kelleher AD; Al-Harthi L; Landay AL
    AIDS; 1997; 11 Suppl A():S149-55. PubMed ID: 9451979
    [No Abstract]   [Full Text] [Related]  

  • 30. Postexposure immunotherapy of simian immunodeficiency virus (SIV) infected rhesus with an SIV immunogen.
    Gardner MB; Jennings M; Carlson JR; Lerche N; McGraw T; Luciw P; Marx P; Pedersen N
    J Med Primatol; 1989; 18(3-4):321-8. PubMed ID: 2547966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SAMHD1 host restriction factor: a link with innate immune sensing of retrovirus infection.
    Sze A; Olagnier D; Lin R; van Grevenynghe J; Hiscott J
    J Mol Biol; 2013 Dec; 425(24):4981-94. PubMed ID: 24161438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Basic science summary.
    Stevenson M
    Top HIV Med; 2009; 17(2):30-4. PubMed ID: 19401604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Possibility of immunotherapy against HIV infection].
    Matsushita S
    Tanpakushitsu Kakusan Koso; 2001 Apr; 46(5):638-43. PubMed ID: 11296361
    [No Abstract]   [Full Text] [Related]  

  • 34. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of recombinant soluble CD4 in rhesus monkeys infected with simian immunodeficiency virus of macaques.
    Watanabe M; Reimann KA; DeLong PA; Liu T; Fisher RA; Letvin NL
    Nature; 1989 Jan; 337(6204):267-70. PubMed ID: 2536140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4.
    Nicolás D; Ambrosioni J; Paredes R; Marcos MÁ; Manzardo C; Moreno A; Miró JM
    Expert Rev Anti Infect Ther; 2015 Aug; 13(8):947-63. PubMed ID: 26112187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotherapy for HIV.
    Krowka JF; Sheppard HW; Ascher MS
    Lancet; 1997 Feb; 349(9049):434. PubMed ID: 9033497
    [No Abstract]   [Full Text] [Related]  

  • 38. Immune-based interventions in HIV infection: doing the right studies, getting the right answers.
    Bart PA; Pantaleo G
    AIDS; 2006 Feb; 20(4):617-8. PubMed ID: 16470127
    [No Abstract]   [Full Text] [Related]  

  • 39. HIV vaccine study approved.
    Expert Rev Vaccines; 2010 Jul; 9(7):693. PubMed ID: 20624040
    [No Abstract]   [Full Text] [Related]  

  • 40. Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy.
    Caskey M; Klein F; Nussenzweig MC
    N Engl J Med; 2016 Nov; 375(21):2019-2021. PubMed ID: 27959740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.